Headquartered in Stockholm, Alder Therapeutics AB is a development stage, private biotechnology company focused on building a novel cell therapy platform with best functional cells based on the most simple and robust processes. The unique platform...

Avenna is a Medtech company developing in-vitro diagnostic platform technology called  GlyHealth, which can detect prodromal signals of inflammatory diseases from a small blood sample.

Cartesian Therapeutics is a fully integrated, clinical-stage biopharmaceutical company developing novel cell and gene immunotherapies to treat cancer and autoimmune diseases. 

Cellivia is a biotechnology company that creates innovative solutions used in biotechnology, medicine, and robotics. The main goal of Cellivia's research is the development of regenerative medicine and technology for the production of medical...

Countagen develops quality control tools for gene editing methods to enable and accelerate research and development.Our first product is a simple-to-use consumable reagent kit that allows users to analyse gene editing efficiency and specificity. Our ...

Curenetics aims to optimise cancer treatment by improving the prediction of immunotherapy cancer treatment response, toxicity, and resistance through data-driven approaches. Our goal is to leverage clinical, genomic, and histological biomarker data...

ExCEEd Orphan was established in July 2018 by 5 experienced and passionate industry professionals with the aim to provide comprehensive commercialisation services for biopharmaceutical companies not present directly in Central & Eastern Europe...

Fusix Biotech is a spin-out from the Technical University of Munich that aims to develop and commercialize a proprietary “best-in-class” oncolytic virus-based immunotherapy platform to treat cancer patients across multiple solid tumor types. Their...

Integra Therapeutics is a biotechnology company that is creating next-generation gene writing tools to make advanced therapies safer and more effective. The company was founded in 2020 as a spin-off of Pompeu Fabra University (UPF) by Dr Marc Güell...

iotaSciences provides instrumentation to facilitate and simplify applications that require single-cell isolation, such as cell line development, genome editing and omics-based analyses. Using automated fluid handling, our single-cell isolation...

Kano Therapeutics harnesses the power of DNA nanotechnology and synthetic biology to design and engineer novel ssDNA gene vectors. Our goal is to expand the reach of genome-editing-based therapies through the development of transformational...

PackGene is a world-leading AAV vector packaging CRO and CDMO. Founded in Massachusetts, USA. PackGene now has offices in Guangzhou, Shanghai, Boston, Houston, and Zurich. We work with customers to support gene therapy programs from early-stage...

ReproGo is a Queen’s University Belfast biotech spinout specializing in the generation of patient-specific induced pluripotent stem cells (iPSCs) and their differentiation towards highly functional vascular cells, vessels, organoids and organs for...

SomaServe is a genetic medicines company exploiting a targeted polymer nanoparticle technology called polyNaut, which can deliver genetic materials to cells and tissues of choice, including targeted delivery to the CNS.PolyNaut technology addresses...

Stimuliver was founded in 2021 by Prof. David Hay and Dr. Dagmara Szkolnicka. The company is based in Copenhagen at the BioInnovation Institute (BII) and is currently funded by the BII’s Venture House programme and Vækstfonden -...

Based in Cambridge, MA, STRM.BIO (“storm bio”) is a pre-clinical, VC-backed biotechnology company that aims to fulfill the promise of gene therapy by leveraging extracellular vesicles (EVs) to deliver treatment directly to the patient (in...

EVOMEDIS is a research & and development stage life science company focused on the development of new therapies for the treatment of wounds, especially burn wounds. We develop a portfolio of inhouse projects based on pharmaceuticals and medical...

DropGenie is making personalized cellular therapies a reality with a unique automation platform that enables low volume high throughput discovery in precious donor cells.

SYTE.bio is a cutting-edge preclinical stage Synthetic Biology company focused on the discovery, development, and commercialization of precision synthetic DNA & RNA-based therapeutics. The company has developed simple, yet powerful, Linear DNA...

a:head’s drug discovery approach is based on human cerebral organoids, a revolutionary, paradigm-shifting new technology that allows the generation of mini brains from human stem cells in vitro. They capture the essential aspects of human embryonic...

Eikonoklastes is advancing a new generation of tissue factor (TF) immunotherapies – therapeutics designed to target the cell surface receptor now known to be prevalent on key components of the tumor microenvironment. It has recently been discovered...

Teiko.bio was founded with a simple purpose: use immune insights to help deliver life-changing therapies to those who need them most. Our end-to-end solution removes barriers to using mass cytometry, to more effectively identify drug targets for...

Lupagen is a privately held early stage biotech company developing first-in-class bedside enabled cell & gene therapies (CAR-T cell, gene editing and immunotherapy products) based on their patent-pending bedside point-of-care C&GT production ...

At the core of all diseases is intracellular environmental change. Here at MicroQuin we are using proprietary small molecules, synthetic peptides and gene therapies to modulate intracellular environment to create new, and transform...

Cellcolabs is a biotech impact start-up specializing in industrial GMP production of high-quality Mesenchymal Stromal Cells (MSC), in order to make them available at scale.We have seen first-hand how patients who could have been significantly helped ...

Stratosvir’s aim is to provide durable treatments for cancer patients through engineering potent and safe viral therapeutics that can be delivered systemically to reach visceral tumours /disseminated metastases. These viruses could potentially...

Driven by science and a passion for quality, STEMCELL Technologies offers over 2500 tools and services to support discoveries in fields such as regenerative medicine, immunotherapy, and disease research. Whether you're culturing and editing...

AVATAMED is a global precision medicine company based in Singapore. It is a A*STAR spin-off from the international PuRPOSE Research Programme between Samsung Medical Centre, A*STAR Singapore, National Cancer Centre Singapore, and National University ...

Cryoniss is a UK-based outsourced managed service provider of temperature-controlled, biological sample storage and cold-chain logistics solutions, founded by former senior leaders of the global AstraZeneca cell banking operation, Sonia Houghton and ...

Edity is developing a novel delivery platform that uses immune cells to transfer therapeutic proteins to the target cells of patients.  Our technology allows for precise modulation of intracellular pathways of disease using a range of proteins...

EVerZom is a spin off from the University of Paris/CNRS developing a cGMP manufacturing platform of exosomes at large scale. The platform is based on patented technologies that enables to produce exosomes with a 100 fold yield increase.The company...

KML Vision, an award-winning DeepTech company, provides intuitive and accessible software solutions specifically designed for the life scientists on the IKOSA Platform.Focused on microscopy, KML Vision creates with IKOSA a disruptive user experience ...

Lupagen is a privately held early stage biotech company developing first-in-class bedside enabled cell & gene therapies (CAR-T cell, gene editing and immunotherapy products) based on their patent-pending bedside point-of-care C&GT production ...

Mesenbio delivers next-generation medicine.Mesenbio is a preclinical stage biopharmaceutical company, spun out of the University of York. Our Cell Line Extracellular Vesicle Release (CLEVR) platform enables us to pursue a varied therapeutic pipeline ...

Cell and gene therapy promises to one day cure any pathology; Modulari-T’s MARC Platform produces the tools to fulfill that promise. The MARCs or Modular Actuation Receptor Complex are a new modality of receptor design to address the shortcomings of ...

MUVON Therapeutics is a clinical stage Life Science Spin-off from the University of Zurich developing an autologous cell therapy for the regeneration of skeletal muscle tissue aiming to provide safe and effective treatments to millions of patients...

OXvax Ltd. is a spin out company from the University of Oxford focused on the development of an advanced next generation dendritic cell vaccine platform for the treatment of solid tumour cancers.The Company’s technology is based on intellectual...

Rinri Therapeutics Ltd. is a therapeutic discovery and development company working to develop advanced therapies for hearing loss, a global condition affecting millions with no approved therapies and poor patient outcomes.  Rinri is leveraging its...

Over 5% of newborns suffer from a genetic disease. These include single gene, polygenic and chromosomal disorders. Many other non-congenital diseases with genetic components are activated by environmental triggers (autoimmune, cancer, tissue...

Single Cell Discoveries is a dedicated service provider for single-cell RNA sequencing. Based in Utrecht, the Netherlands, we provide universities, biotech and pharma worldwide with high-quality single-cell RNA sequencing and bulk RNA sequencing...

StemSight is developing off-the-shelf therapies to cure corneal blindness using human induced pluripotent stem cells

The Sample Network provides human biological samples and associated services to support biomarker development, diagnostic and pharmaceutical research.The team behind The Sample Network has created one of the largest virtual biobanks globally, with...